||Registry of biomedical companies:
  [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 648 active entries
Kosmonavta Volkova 6a-1205
GERO (ex Quantum Pharmaceuticals) is a drug discovery company designing first in class small molecule therapeutics using proprietary, industry leading molecular modeling and systems biology technologies.
Since being established in 2004, the company has developed a portfolio of preclinical, first in class small molecules against high-interest targets in cancer metabolism, diabetes, and neuroprotection.
Recently, our focus has turned to developing new medicines to combat the aging process and extend healthy human lifespans. We have developed new insights into aging biology, primarily around the stability and stress resistance of certain gene regulatory networks 1.
- Our research has revealed new druggable targets which we believe will translate into innovative medicines to delay a number of age related diseases, including human frailty and mortality itself . By combining our powerful molecular modelling capabilities with our insights into the biology of important new drug targets, we are developing a portfolio of new medicines which delay human mortality while maintaining a high quality of life.
Last update of this entry: August 06, 2015
Bookmark and Share this page (what is this?)
Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.
Use the links below to share this article on the social bookmarking site of your choice.
Read more about social bookmarking at Wikipedia - Social Bookmarking